- Presentations
- 6
- Markets
- 1
Vimpat is a brand of Lacosamide marketed by UCB, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Lacosamide
- Brand owner
- UCB
- Registered in
- United States
- Strengths and forms
- 200 mg/20 mL injection, 10 mg/mL oral solution, 100 mg tablet, 150 mg tablet, 200 mg tablet, 50 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Vimpat 200 mg/20 mL injectionIntravenous | UCB | US FDA | Available on request |
| Vimpat 10 mg/mL oral solutionOral | UCB | US FDA | Available on request |
| Vimpat 100 mg tabletOral | UCB | US FDA | Available on request |
| Vimpat 150 mg tabletOral | UCB | US FDA | Available on request |
| Vimpat 200 mg tabletOral | UCB | US FDA | Available on request |
| Vimpat 50 mg tabletOral | UCB | US FDA | Available on request |
Equivalent brands
Other brands of Lacosamide.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Vimpat
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.